Transfusion and Apheresis Science 2013-06-01

Which regimen is better for stem cell mobilization of lymphoma patients?

Sinem Civriz Bozdağ, Emre Tekgündüz, Gamze Durgun, Abdurrahman Sarıca, Itır Şirinoğlu Demiriz, Serife Koçubaba, Fevzi Altuntaş

Index: Transfus. Apher. Sci. 48(3) , 407-10, (2013)

Full Text: HTML

Abstract

Although chemotherapy combined with G-CSF is an effective method for hematopoietic stem cell mobilization, standard chemotherapy protocol leading to best stem cell yield is not defined. In our study, we aimed to assess the impact of chemotherapy choice on mobilization outcome in lymphoma patients. Patients were mobilized with cyclophosphamide (n:15), ASHAP (n:11) or VGEPP (n:12) protocols. Groups were similar according to collected CD34+ cell count, total nucleated cell count and median apheresis days. Five out of fifteen (33%) patients could not be mobilized in Cy group but there was only one failed mobilization attempt in both salvage groups (9% with ASHAP vs 8% with VGEPP). In conclusion, we showed that VGEPP and ASHAP are safe protocols in terms of stem cell mobilization and have similar mobilization capacity as cyclophosphamide alone.Copyright © 2013 Elsevier Ltd. All rights reserved.

Related Compounds

  • Methylprednisolone...

Related Articles:

Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids.

2013-09-01

[Cancer Chemother. Pharmacol. 72(3) , 509-13, (2013)]

A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest.

2012-01-01

[BMJ Case Rep. 2012 , doi:10.1136/bcr-2012-006868, (2012)]

Shoe contact dermatitis: a case report of an acute severe reaction to potassium dichromate.

2012-09-01

[Foot (Edinb.) 22(3) , 141-5, (2012)]

Ex vivomodels to evaluate the role of ocular melanin in trans-scleral drug delivery

2012-08-15

[Eur. J. Pharm. Sci. 46(5) , 475-83, (2012)]

Successful treatment of anti-Caspr2 syndrome by interleukin 6 receptor blockade through tocilizumab.

2013-08-01

[JAMA Neurol. 70(8) , 1056-9, (2013)]

More Articles...